Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer

Background Microsatellite instability (MSI) is an important prognosticator for colorectal cancer (CRC).

The present study aimed to assess the impact of MSI status on the characteristics and outcomes of early-onset compared to late-onset rectal cancer.

Methods This retrospective cohort study used data from the US National Cancer Database (2004–2019) to assess the baseline characteristics, treatment patterns, short-term outcomes, and overall survival (OS) of early-onset rectal adenocarcinoma affecting patients < 50 years compared to late-onset rectal adenocarcinoma according to the MSI status.

Results The present study included 48,407 patients (59.9% male) with rectal cancer, 17.3% of patients were < 50 years and 6.3% had MSI-H tumors.

In the early-onset group, patients with MSI-H tumors had a lower mean age (41.5 vs 43 years, p  < 0.001) and presented less often with stage IV disease (22.1% vs 17.7%, p  = 0.03) and liver metastasis (9.1% vs 13.5%, p  = 0.011) than patients with MSS tumors.

In the late-onset group, patients with MSI-H and MSS tumors had similar demographics, disease stage, and metastatic pattern, yet MSI-H patients more often received neoadjuvant radiation therapy (58.9% vs 55.1%, p  = 0.009) and neoadjuvant systemic therapy (40% vs 36.2%, p  = 0.005).

In both age groups, MSI-H tumors were associated with more pathologic T3-4 stage and were more likely mucinous and poorly differentiated carcinomas than MSS tumors.

The median OS of MSI-H tumors was similar to MSS tumors (108.09 vs 102.31 months, p  = 0.1), whether in the early-onset (139.5 vs 134.2 months, p  = 0.821) or late-onset groups (106.1 vs 104.3 months, p  = 0.236).

Conclusions In both age groups, MSI-H rectal cancers were more often mucinous and poorly differentiated carcinomas and had pT3-4 stage more often than MSS cancers.

MSI-H rectal cancers tend to present less often with distant metastases and nodal involvement than MSS cancers only in early-onset, but not in late-onset rectal cancers.

The association between MSI status and survival was not notable in this study, whether in the early-onset or late-onset groups.